SOMERSET, N.J., Dec. 28, 2022 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: MTBC, MTBCO, MTBCP), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced Alpine Ear Nose and Throat PC has selected CareCloud’s Meridian division’s revenue cycle management solution to support its administrative operations and improve cashflow for the Colorado-based practice.
With three locations serving Northern Colorado, Alpine offers general ear, nose and throat (ENT) services, audiology, allergy and vestibular therapy, as well as facial plastics. Alpine selected Meridian through trusted referrals that endorsed Meridian’s medical billing experience and prior success in streamlining processes, eliminating coding errors, and improving service-level agreements.
Meridian’s end-to-end RCM is supported through market-leading technology and provides data analytics to help practices track powerful key performance indicators and improve their decision-making. As a member of the CareCloud family with integrated business intelligence and operational management tools, Meridian offers powerful solutions to manage the business side of a medical practice more efficiently. It helps providers increase cash flow, reduce days in aged receivables, improve work efficiencies and keep back-office functions current, so providers can focus on care delivery. With flexibility and various resources, Meridian can also quickly address operational and technology needs as they arise.
“Alpine had never outsourced their billing operations before, so they wanted an RCM solution they could trust to improve their back-end operations without adding stress,” said Crystal Williams, Meridian’s vice president of operations. “The coding education offered through Meridian’s RCM, paired with its ability to enhance and streamline administrative tasks, removed the anxiety that comes with making this kind of decision. We’re looking forward to working with Alpine to improve their key performance indicators and maximize their revenue.”
A subsidiary of CareCloud, Meridian not only offers RCM, but also delivers advanced healthcare information technology solutions and services to thousands of healthcare providers nationwide. Learn more about how Meridian can help providers navigate the complex and ever-changing healthcare systems of today at m3meridian.com.
About CareCloud
CareCloud (Nasdaq: MTBC, MTBCO, MTBCP) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, telehealth and patient experience management (PXM) at www.carecloud.com.
Follow CareCloud on LinkedIn, Twitter and Facebook.
Company Contact:
Bill Korn
Chief Financial Officer
CareCloud
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Contact:
Asher Dewhurst
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Inquiries:
Alexis Feinberg
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$2.02 |
Daily Change: | -0.04 -1.71 |
Daily Volume: | 169,526 |
Market Cap: | US$32.760M |
May 06, 2025 April 07, 2025 April 02, 2025 March 26, 2025 March 13, 2025 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORECompass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREEnd of content
No more pages to load